Genomictree Inc.

Genomictree Inc. - PE Ratioverified

228760.KQ

Price:

$12080

Market Cap:

$296.28B

Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports...[Read more]

Industry

Biotechnology

IPO Date

2016-07-19

Stock Exchange

KOE

Ticker

228760.KQ

The PE Ratio as of August 2026 (TTM) for Genomictree Inc. (228760.KQ) is -30.27

According to Genomictree Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -30.27. This represents a change of -43.72% compared to the average of -53.79 of the last 4 quarters.

Genomictree Inc. (228760.KQ) Historical PE Ratio (quarterly & annually)

How has 228760.KQ PE Ratio performed in the past?

The mean historical PE Ratio of Genomictree Inc. over the last ten years is -55.30. The current -30.27 PE Ratio has changed 5.37% with respect to the historical average. Over the past ten years (40 quarters), 228760.KQ's PE Ratio was at its highest in in the March 2022 quarter at 5.22. The PE Ratio was at its lowest in in the December 2023 quarter at -98.85.

Quarterly (TTM)
Annual

Average

-55.30

Median

-45.82

Minimum

-174.38

Maximum

-24.03

Genomictree Inc. (228760.KQ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Genomictree Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 246.46%

Maximum Annual PE Ratio = -24.03

Minimum Annual Increase = -74.79%

Minimum Annual PE Ratio = -174.38

Quarterly (TTM)
Annual
YearPE RatioChange
2025-73.3453.84%
2024-47.68-20.51%
2023-59.97120.04%
2022-27.2613.41%
2021-24.03-3.18%
2020-24.82-43.53%
2019-43.96-74.79%
2018-174.38246.46%
2017-50.3384.93%

Genomictree Inc. (228760.KQ) Average PE Ratio

How has 228760.KQ PE Ratio performed in the past?

The current PE Ratio of Genomictree Inc. (228760.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-60.33

5-year avg

-46.46

10-year avg

-55.30

Genomictree Inc. (228760.KQ) PE Ratio vs. Peers

How is 228760.KQ’s PE Ratio compared to its peers?

Genomictree Inc.’s PE Ratio is less than Proteina Co., Ltd. (0), less than BINEX Co., Ltd. (-7.26), less than MEDIPOST Co., Ltd. (-12.26), less than SillaJen, Inc. (-12.70), less than Bioneer Corporation (-11.64), less than Orum Therapeutics, Inc. (27.44), greater than Helixmith Co., Ltd (-86.61), less than Onconic Therapeutics (26.72), less than GC Corp. (-3.70), less than GC Corp. (-27.91),

Build a custom stock screener for Genomictree Inc. (228760.KQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomictree Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genomictree Inc. (228760.KQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genomictree Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Genomictree Inc.'s PE Ratio?

How is the PE Ratio calculated for Genomictree Inc. (228760.KQ)?

What is the highest PE Ratio for Genomictree Inc. (228760.KQ)?

What is the 3-year average PE Ratio for Genomictree Inc. (228760.KQ)?

What is the 5-year average PE Ratio for Genomictree Inc. (228760.KQ)?

How does the current PE Ratio for Genomictree Inc. (228760.KQ) compare to its historical average?